HUMAN CORD BLOOD CELL CONDITIONED MEDIA
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Growth medium from cultured human umbilical cord blood cells, containing blood-cell-derived signalling molecules with potential anti-inflammatory properties.
Human cord blood cell conditioned media is restricted under EU Annex II/416 as a material of human origin. Umbilical cord blood is a recognised source of haematopoietic stem cells, making sourcing ethically sensitive and subject to blood safety regulations. The media contains undefined blood cell secretions including cytokines and potential growth factors. CAS number 811903-86-5 is registered in PubChem for this material.
Skin benefits
- Contains cord blood-derived cytokines with potential immunomodulatory effects
- May include haematopoietic growth factors
Known concerns
- EU Annex II/416 restriction
- Ethical and consent issues around cord blood sourcing
- Blood-borne pathogen screening mandatory
- Undefined secretome composition
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Check your shelf
Find HUMAN CORD BLOOD CELL CONDITIONED MEDIA in your products.
Scan any cosmetic product with LuxSense to see if it contains HUMAN CORD BLOOD CELL CONDITIONED MEDIA and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.